BIOSCRUB Drug Patent Profile
✉ Email this page to a colleague
When do Bioscrub patents expire, and when can generic versions of Bioscrub launch?
Bioscrub is a drug marketed by Griffen and is included in one NDA.
The generic ingredient in BIOSCRUB is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bioscrub
A generic version of BIOSCRUB was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BIOSCRUB?
- What are the global sales for BIOSCRUB?
- What is Average Wholesale Price for BIOSCRUB?
Summary for BIOSCRUB
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Patent Applications: | 6,899 |
DailyMed Link: | BIOSCRUB at DailyMed |
US Patents and Regulatory Information for BIOSCRUB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Griffen | BIOSCRUB | chlorhexidine gluconate | SPONGE;TOPICAL | 019822-001 | Mar 31, 1989 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |